| 【英語論文】 |
| |
原著論文 |
| |
|
1. Witzig TE, Tobinai K, Rigacci L, Ikeda T, Vanazzi A, Hino M, Shi Y, Mayer J, Costa LJ, Bermudez Silva CD, Zhu J, Belada D, Bouabdallah K, Kattan JG, Kuruvilla J, Kim WS, Larouche JF, Ogura M, Ozcan M, Fayad L, Wu C, Fan J, Louveau AL, Voi M and Cavalli F: Adjuvant everolimus in high-risk diffuse large B-cell lymphoma: final results from the PILLAR-2 randomized phase III trial. Annals of Oncology., 29, 707-714, 2018. |
| |
|
2. Aoyama T, Imataki O, Arai H, Kume T, Shiozaki H, Katsumata N, Mori M, Ishide K and Ikeda T: Comparison of Nutrition-Related Adverse Events and Clinical Outcomes Between ICE (Ifosfamide, Carboplatin, and Etoposide) and MCEC (Ranimustine, Carboplatin, Etoposide, and Cyclophosphamide) Therapies as Pretreatment for Autologous Peripheral Blood Stem Cell Transplantation in Patients with Malignant Lymphoma. Medical Science Monitor Basic Research, 24, 31-39, 2018. |
| |
|
3. Kawamura K, Tsukada N, Kanda Y, Ikeda T, Yoshida A, Ueda Y, Ishida T, Suzuki K and Murakami H: The role of allogeneic transplantation for multiple myeloma in the era of novel agents: A study from the Japanese Society of Myeloma. Biology of Blood and Marrow Transplantation, 24, 1392-1398, 2018. |
| |
|
4. Akiyama K, Kume T, Fukaya M, Shiki I, Enami T, Tatara R, Shino M and Ikeda T: Comparison of levetiracetam with phenytoin for the prevention of intravenous busulfan-induced seizures in hematopoietic cell transplantation recipients. Cancer Chemotherapy Pharmacology. 82, 717-721, 2018. |
| |
|
5. Itonaga H, Ota S, Ikeda T, Taji H, Amano I, Hasegawa Y, Ichinohe T, Fukuda T, Atsuta Y, Tanizawa A, Kondo T and Miyazaki Y: Allogeneic hematopoietic stem cell transplantation for the treatment of BCR-ABL1-negative atypical chronic myeloid leukemia and chronic neutrophil leukemia: A retrospective nationwide study in Japan. Leukemia Research, 75, 50-57, 2018. |
| |
総説 |
| |
|
Hirayama F, Yasui K, Matsuyama N and Okamura-Shiki I: Possible utility of the basophil activation test for the analysis of mechanisms involved in allergic transfusion reactions. Transfusion Medicine Reviews, 32, 43-51,2018. |
| |
|
|
| 【和文論文】 |
| |
症例報告 |
| |
|
1. 式(岡村)郁恵、松山宣樹、保井一太、平山文也、池田 宇次:アナフィラキシーを発症した骨髄移植患者血液と当該血小板残余試料を用いた好塩基球活性化試験および受身好塩基球活性化試験の継時的検討. 日本輸血細胞治療学会誌, 64, 649-654,2018. |
